News
Star Bio Pharma Rebrands as Star Bio Pharma Global Pvt. Ltd. , Marking a New Chapter in Global Expansion
18+ hour, 39+ min ago (510+ words) India Med Today Star Bio Pharma has announced its transition to Star Bio Pharma Global Pvt. Ltd. , signalling a new phase of growth focused on international markets and innovation-led expansion. The rebranding reflects the company's ambition to strengthen its global…...
Immunome's $4. 39 Million Insider Sale: A Pre-Planned Exit Amidst Robust Pipeline Momentum
20+ hour, 2+ min ago (949+ words) Kavout | AI Immunome's $4. 39 Million Insider Sale: A Pre-Planned Exit Amidst Robust Pipeline Momentum - Immunome director Isaac Barchas recently sold over $4. 39 million in IMNM shares, but these transactions were executed under a pre-arranged Rule 10b5-1 trading plan. - Immunome has reported significant clinical…...
Anthropic targets drug discovery for neglected diseases with Claude Science initiative
10+ hour, 28+ min ago (261+ words) The AI lab's new research platform integrates over 60 scientific tools and pairs with an internal drug discovery program focused on conditions big pharma ignores The platform connects to more than 60 scientific tools and databases, including Pub Med and Jupyter, and…...
DJS Stock and Shares Ltd Exits Legacy Business After Shareholder Approval
13+ hour, 30+ min ago (310+ words) DJS Stock and Shares Limited shareholders approved resolutions to exit legacy trading and clearing activities. This signals a major business pivot, with extensive MOA/AOA changes and a potential company name change on the horizon. Shareholders of DJS Stock and…...
Divis Laboratories: What Should Investors Do?
10+ hour, 8+ min ago (645+ words) Divis Laboratories benefits from strong CDMO demand but faces high valuations, prompting a hold recommendation for investors. Divis Laboratories: What should investors do? Demand for CDMO favours Divis Laboratories, but valuations remain high Investor interest in Divis Laboratories continues to…...
Step into or stuck in the upper middle?
6+ hour, 28+ min ago (716+ words) Every afternoon, from Grade 5 through the end of high school, I went straight from school to the golf course. Not" Myka Romulo4 July 2026 Twenty-six years is a long time to hold the line. The Tribune has held it, imperfectly and under…...
Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics - AOL
13+ hour, 9+ min ago (238+ words) As momentum in the global nucleic acid medicine sector continues to build, advances in chemistry, delivery systems, manufacturing, and clinical research are broadening the therapeutic applications of these modalities. The event provided a platform for stakeholders across the value chain…...
i PSC Aggregate Culture In Bioreactors Equipped With 8-Blade Impellers
12+ hour, 48+ min ago (167+ words) Bioprocess Online i PSC Aggregate Culture In Bioreactors Equipped With 8-Blade Impellers Advancing induced pluripotent stem cell (i PSC) processes from research to scalable, controlled environments requires tight command over aggregation, oxygen transfer, and shear conditions. Integrated mini bioreactor platforms…...
Deepalchemy - AI Drug Discovery - Reviews & Alternatives
15+ hour, 11+ min ago (122+ words) Startup Hub. ai AI-powered platform for drug discovery and development, accelerating research and reducing costs. No comments yet. Be the first to share your take. What does Deepalchemy do? Deepalchemy is an AI-driven platform designed to revolutionize drug discovery and…...
Anthropic enters drug development: Claude maker to sell pharma software
15+ hour, 17+ min ago (256+ words) Anthropic enters drug development arena inkorr. com Anthropic enters drug development arena Company behind Claude steps into pharmaceutical market According to " " ": Anthropic, the organization renowned for creating the Claude AI system, has announced its expansion into drug development. Eric Kauderer-Abrams,…...